$Theravance Biopharma(TBPH)$ 8-K - Current report Filed: 2019-01-07 AccNo: 0001104659-19-001153 Size: 5 MBItem 2.05: Cost Associated with Exit or Disposal ActivitiesItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接